Anna Dubrovska
Affiliations: | 2007- | Scripps Research Institute |
Google:
"Anna Dubrovska"Mean distance: (not calculated yet)
Children
Sign in to add traineeIelizaveta Gorodetska | grad student | TU Dresden | |
Linda Hein | grad student | 2014- | TU Dresden |
David Digomann | grad student | 2015- | TU Dresden |
Anna Tyutyunnykova | grad student | 2015- | TU Dresden |
Iñaki Schniewind | grad student | 2016- | TU Dresden |
Monica Cojoc | grad student | 2012-2015 | TU Dresden |
Claudia Peitzsch | post-doc | 2012- | TU Dresden |
Ina Kurth | post-doc | 2012-2015 | TU Dresden |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Samaržija I, Lukiyanchuk V, Lončarić M, et al. (2024) The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells. Frontiers in Cell and Developmental Biology. 12: 1452463 |
Beier AK, Ebersbach C, Siciliano T, et al. (2024) Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer. Oncogene |
Schniewind I, Besso MJ, Klicker S, et al. (2024) Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer. Cancers. 16 |
Mehralivand S, Thomas C, Puhr M, et al. (2024) New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. Journal of Translational Medicine. 22: 71 |
Gorodetska I, Offermann A, Püschel J, et al. (2024) ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics. 14: 714-737 |
Philchenkov A, Dubrovska A. (2023) Cancer stem cells as a therapeutic target: current clinical development and future prospective. Stem Cells (Dayton, Ohio) |
Xia P, Dubrovska A. (2023) CD98 heavy chain as a prognostic biomarker and target for cancer treatment. Frontiers in Oncology. 13: 1251100 |
Köseer AS, Di Gaetano S, Arndt C, et al. (2023) Immunotargeting of Cancer Stem Cells. Cancers. 15 |
Klusa D, Lohaus F, Franken A, et al. (2023) Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy. International Journal of Cancer |
Linke D, Donix L, Peitzsch C, et al. (2022) Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. International Journal of Molecular Sciences. 24 |